Can we offer better, more personalised care for people with shoulder pain?

Maximising outcome for patients with shoulder pain: using optimal diagnostic and prognostic information to target treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN45377604

Enrollment

832

Registered

2023-06-15

Start date

2023-06-30

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder pain Musculoskeletal Diseases

Interventions

The design of the trial is a cluster-randomised controlled trial. The physiotherapy services are the unit of randomisation and will be randomised to either deliver the guided consultation of shoulder

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients referred or self-referred to participating physiotherapy services 2. Aged 18 years or over 3. Presenting with shoulder pain

Exclusion criteria

Exclusion criteria: 1. Present to the physiotherapy service with symptoms or signs indicative of serious pathology (e.g. fractures, infection, inflammation, malignancy or referred pain from other sites (e.g. cardiac, hepatobiliary)) 2. Have shoulder pain caused by stroke-related subluxation 3. Been referred for rehab post-surgery 4. Have a diagnosis of inflammatory arthritis, including rheumatoid arthritis, and polymyalgia rheumatica 5. Have shoulder pain caused by cervical pathology or predominantly neck pain 6. Are considered by the staff triaging to be vulnerable (e.g. severe physical and/or mental health problems, dementia)

Design outcomes

Primary

Measure	Time frame
Shoulder pain and disability are measured using the Shoulder Pain and Disability Index (SPADI) at baseline, 6 weeks, 6 months and 12 months	—

Secondary

Measure	Time frame
1. Perceived change in shoulder pain symptoms will be measured using the Global Perceived Change single-item question at 6 weeks, 6 months, and 12 months 2. Sleep difficulties will be measured using the Jenkins Sleep Questionnaire at baseline, 6 weeks, 6 months and 12 months 3. Work absence will be measured by asking how many days off a participant has had in the past days/weeks at baseline, 6 months and 12 months 4. Work performance will be measured using the single-item work performance VAS scale at baseline, 6 months and 12 months 5. Healthcare utilisation will be measured using standardised items at 6 months and 12 months 6. Health-related quality of life will be measured using the EQ-5D-5L at baseline, 6 weeks, 6 months and 12 months	—

Measure

Time frame

1. Perceived change in shoulder pain symptoms will be measured using the Global Perceived Change single-item question at 6 weeks, 6 months, and 12 months 2. Sleep difficulties will be measured using the Jenkins Sleep Questionnaire at baseline, 6 weeks, 6 months and 12 months 3. Work absence will be measured by asking how many days off a participant has had in the past days/weeks at baseline, 6 months and 12 months 4. Work performance will be measured using the single-item work performance VAS scale at baseline, 6 months and 12 months 5. Healthcare utilisation will be measured using standardised items at 6 months and 12 months 6. Health-related quality of life will be measured using the EQ-5D-5L at baseline, 6 weeks, 6 months and 12 months

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026